These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19924579)

  • 21. Liver-related mortality is similar among men and women with cirrhosis.
    Mazumder NR; Celaj S; Atiemo K; Daud A; Jackson KL; Kho A; Levitsky J; Ladner DP
    J Hepatol; 2020 Nov; 73(5):1072-1081. PubMed ID: 32344052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with cirrhosis in the ED: early predictors of infection and mortality.
    Ximenes RO; Farias AQ; Scalabrini Neto A; Diniz MA; Kubota GT; Ivo MM; Colacique CG; D'Albuquerque LA; Daglius Dias R
    Am J Emerg Med; 2016 Jan; 34(1):25-9. PubMed ID: 26423777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care.
    Innes HA; Hutchinson SJ; Allen S; Bhattacharyya D; Bramley P; Delahooke TE; Dillon JF; Forrest E; Fraser A; Gillespie R; Goldberg DJ; Kennedy N; McDonald S; McLeod A; Mills PR; Morris J; Hayes P;
    Hepatology; 2011 Nov; 54(5):1547-58. PubMed ID: 22045672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis.
    McDonald SA; Pollock KG; Barclay ST; Goldberg DJ; Bathgate A; Bramley P; Dillon JF; Fraser A; Innes HA; Kennedy N; Morris J; Went A; Hayes PC; Hutchinson SJ
    J Viral Hepat; 2020 Mar; 27(3):270-280. PubMed ID: 31696575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
    Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
    JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality Rates in Patients With Chronic Hepatitis C and Cirrhosis Compared With the General Population: A Danish Cohort Study.
    Hallager S; Brehm Christensen P; Ladelund S; Rye Clausen M; Lund Laursen A; Møller A; Schlicthting P; Galmstrup Madsen L; Gerstoft J; Lunding S; Elmegaard Grønbæk K; Bygum Krarup H; Weis N
    J Infect Dis; 2017 Jan; 215(2):192-201. PubMed ID: 27803168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic liver injury induced by drugs and toxins.
    Ortega-Alonso A; Andrade RJ
    J Dig Dis; 2018 Sep; 19(9):514-521. PubMed ID: 29808546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU.
    Gildea TR; Cook WC; Nelson DR; Aggarwal A; Carey W; Younossi ZM; Arroliga AC
    Chest; 2004 Nov; 126(5):1598-603. PubMed ID: 15539733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and Outcomes for Patients With Cirrhosis Admitted to the United Kingdom Critical Care Units.
    McPhail MJW; Parrott F; Wendon JA; Harrison DA; Rowan KA; Bernal W
    Crit Care Med; 2018 May; 46(5):705-712. PubMed ID: 29309369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and chronic liver toxicity resulting from exposure to chlorinated naphthalenes at a cable manufacturing plant during World War II.
    Ward EM; Ruder AM; Suruda A; Smith AB; Fessler-Flesch CA; Zahm SH
    Am J Ind Med; 1996 Aug; 30(2):225-33. PubMed ID: 8844054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of hepatotoxic drugs on the outcome of patients with acute deterioration of hepatitis B virus-related chronic disease.
    Sun J; Yu X; Weng Z; Jin L; Yang J; Zhang H; Gu J; Wang N; Yang J
    Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):782-790. PubMed ID: 35506899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.
    Yang SC; Hsu CN; Liang CM; Tai WC; Wu CK; Shih CW; Ku MK; Yuan LT; Wang JW; Tseng KL; Hung TH; Nguang SH; Hsu PI; Wu DC; Chuah SK
    PLoS One; 2017; 12(1):e0168918. PubMed ID: 28081567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study.
    Zhang J; Feng G; Zhao Y; Zhang J; Feng L; Yang J
    BMJ Open; 2015 Aug; 5(8):e008033. PubMed ID: 26297362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study.
    Sobhonslidsuk A; Poovorawan K; Soonthornworasiri N; Pan-Ngum W; Phaosawasdi K
    BMC Gastroenterol; 2016 Oct; 16(1):135. PubMed ID: 27793116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study.
    Ratib S; Fleming KM; Crooks CJ; Walker AJ; West J
    Am J Gastroenterol; 2015 Aug; 110(8):1149-58. PubMed ID: 26169512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased mortality from chronic liver disease and cirrhosis 13 years after the Taiwan "yucheng" ("oil disease") incident.
    Yu ML; Guo YL; Hsu CC; Rogan WJ
    Am J Ind Med; 1997 Feb; 31(2):172-5. PubMed ID: 9028433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sociodemographic characteristics, complications requiring hospital admission and causes of in-hospital death in patients with liver cirrhosis admitted at a district hospital in Ghana.
    Duah A; Agyei-Nkansah A; Osei-Poku F; Duah F; Addo BP
    PLoS One; 2021; 16(6):e0253759. PubMed ID: 34166471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
    Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
    J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.
    Vinikoor MJ; Sinkala E; Mweemba A; Zanolini A; Mulenga L; Sikazwe I; Fried MW; Eron JJ; Wandeler G; Chi BH
    Liver Int; 2015 Jul; 35(7):1886-92. PubMed ID: 25581487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.